GL1X · GenesisL1 explorer

Research workbench

Human kallikrein 6 (HK6) active form with benzamidine inhibitor at 1.56 a resolution

Analyse Human kallikrein 6 (HK6) active form with benzamidine inhibitor at 1.56 a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1LO6
Type
protein
Length
221 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kallikrein 6
UniProt
Q92876
Ligands
BEN, MG
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKallikrein 6protein22110% helix, 38% strandQ92876

Ligands and binding sites

  • BEN · Benzamidine · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1710.370.7720BEN

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1LO6 · Human Kallikrein 6 (hK6) active form with benzamidine inhibitor at 1.56 A resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92876 · AlphaFold monomer V2.0 prediction for kallikrein-6 (Q92876) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.